Free tool
Stocks far below their 52-week high
We cover 8 companies trading at least 50% below their own 52-week high. The median market value in the group is $4.23B. Across the group, the median move over the past trading day is −1.06%. Price change over the past year runs from −62.0% to −23.6% across the middle 80 percent of the group, with a median of −49.0%.
Other lists in this group
Table
8 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| PODD | Insulet Corporation | $143.38 | −14.38% | −49.32% | −57.12% |
| HIMS | Hims & Hers Health, Inc. | $29.83 | +1.74% | −10.72% | −32.22% |
| COH.AX | Cochlear Limited | 136.01 AUD | +11.03% | −47.23% | −53.79% |
| DOCS | Doximity, Inc. | $24.74 | +15.39% | −42.85% | −63.61% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,436.50 JPY | +13.47% | −41.63% | −3.59% |
| RGC | Regencell Bioscience Holdings Limited | $5.50 | −7.87% | −73.22% | −61.38% |
| EBO.AX | EBOS Group Limited | 17.51 AUD | −7.26% | −23.87% | −37.83% |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.